The Arizona Poison and Drug Information Center at the University of Arizona College of Pharmacy and Banner Health's Poison and Drug Information Center in Phoenix are warning residents statewide against using inappropriate medications and botanical products such as oleandrin to prevent or treat COVID-19.

The Michael J. Fox Foundation has awarded more than $8.8 million in wide-ranging grants to scientists aiming to better understand, diagnose and treat Parkinson's disease. One grant recipient is Dr. Lalitha Madhavan, an associate professor in the University of Arizona Department of Neurology at the College of Medicine - Tucson. She and her team are developing a human cellular system to help in the early identification and study of Parkinson’s mechanisms. Specifically, they want to develop dopamine neurons and patient-derived skin cells – called fibroblasts – for use in evaluating in clinical trials potential Parkinson's therapies and biomarkers.

While leading health organizations such as the World Health Organization and Centers for Disease Control and Prevention recommend the use of hand dryers, experts say misinformation about this equipment remains. Kelly Reynolds, a professor and Department Chair at the Mel and Enid Zuckerman College of Public Health at the University of Arizona, offered an explanation as to the root of these misconceptions, stating that, “Consumers may only read (sensationalized) headlines which can influence public opinion toward biased or erroneous conclusions, (but) the fact is, the breadth of data available does not favor one hand drying method as being more hygienic or safer.”

Inappropriate medications – such as oleandrin, a derivative of oleander known to be toxic – used to prevent or treat COVID-19 could cause significant harm and no benefit, University of Arizona Health Sciences-based center and Banner Health center warn.

Bolstered by a $1.6 million grant, Dr. Timothy Bolger, at the University of Arizona Cancer Center, is studying how cells respond to stress and the role this process has in cancer growth and aging.

Understanding how cells respond to stress may provide new building blocks for designing future cancer and aging treatments. Timothy Bolger, a researcher at the University of Arizona Cancer Center, received a $1.6 million grant from the National Institutes of Health to investigate how cells respond to stress and the role this process may have in cancer growth and aging.

A University of Arizona Health Sciences cohort study of more than 50,000 menopausal women showed significant decrease in Alzheimer’s disease diagnosis.

The University of Arizona had its first day of in-person classes Monday as people on and off-campus worry that a rise in cases will inevitably follow students' return to Tucson. "We feel that we've done a very good job about creating an environment that's receptive to our students, staff and faculty returning in the increments we have explained. But they've got to adhere to those public health practices,” said Dr. Richard Carmona, head of the Campus Reentry Task Force and distinguished professor of public health.

Following a dramatic surge of coronavirus cases between June and July, numbers across the United States have largely decreased, which experts attribute to local mask mandates and other precautionary measures, like restaurant and bar closures. Joe Gerald, an associate professor of public health policy at the University of Arizona, attributed the decrease to mask orders in the state's biggest cities, news media coverage of the heightened risk and also the closure of bars, gyms and theaters after they started reopening in May.